GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma

L Kang, Y Liu, J He, Y Wang, M Xue, X Wu, Z Wang… - Oncogene, 2023 - nature.com
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest forms of human
malignancy that currently lacks approved targeted therapeutics. Accumulating evidence …
被引用次数：4 相关文章

GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.

L Kang, Y Liu, J He, Y Wang, M Xue, X Wu, Z Wang… - Oncogene, 2023 - europepmc.org
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest forms of human
malignancy that currently lacks approved targeted therapeutics. Accumulating evidence …

GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma

L Kang, Y Liu, J He, Y Wang, M Xue, X Wu… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest forms of human
malignancy that currently lacks approved targeted therapeutics. Accumulating evidence …